SGHT
Sight Sciences Inc
NASDAQ: SGHT · HEALTHCARE · MEDICAL DEVICES
$4.09
+3.02% today
Updated 2026-04-30
Market cap
$237.20M
P/E ratio
—
P/S ratio
3.07x
EPS (TTM)
$-0.74
Dividend yield
—
52W range
$3 – $9
Volume
0.4M
WallStSmart proprietary scores
25
out of 100
Grade: F
Strong Sell
Investment rating
4.7
Growth
C6.0
Quality
B2.0
Profitability
F6.7
Valuation
B4/9
Piotroski F-Score
Moderate
-1.7
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$8.34
+103.91%
12-Month target
—
—
Intrinsic (DCF)
$8.76
Margin of safety
+36.87%
1 Strong Buy3 Buy2 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ 36.87% below intrinsic value
Risks
- Altman Z -1.72 — distress zone
- Thin margins at -49.70%
- Negative free cash flow $-1.98M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $71.33M | $81.06M | $79.87M | $77.36M | $77.36M |
| Net income | $-86.24M | $-55.55M | $-51.51M | $-38.43M | $-4.16M |
| EPS | — | — | — | — | $-0.74 |
| Free cash flow | $-76.94M | $-47.98M | $-22.74M | $-29.92M | $-1.98M |
| Profit margin | -120.90% | -68.53% | -64.49% | -49.67% | -49.70% |
Peer comparison
Smart narrative
Sight Sciences Inc trades at $4.09. Our Smart Value Score of 25/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -1.72, it sits in the distress. TTM revenue stands at $77.36M. with profit margins at -49.70%. Our DCF model estimates intrinsic value at $8.76.
Frequently asked questions
What is Sight Sciences Inc's stock price?
Sight Sciences Inc (SGHT) trades at $4.09.
Is Sight Sciences Inc overvalued?
Smart Value Score 25/100 (Grade F, Strong Sell). DCF value $8.76.
What is the price target of Sight Sciences Inc (SGHT)?
The analyst target price is $8.34, representing +103.9% upside from the current price of $4.09.
What is the intrinsic value of Sight Sciences Inc (SGHT)?
Based on our DCF model, intrinsic value is $8.76, a +36.9% margin of safety versus $4.09.
What is Sight Sciences Inc's revenue?
TTM revenue is $77.36M.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
-1.72 — distress.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio3.07x
ROE-50.70%
Beta2.49
50D MA$4.25
200D MA$5.09
Shares out0.05B
Float0.04B
Short ratio—
Avg volume0.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—